These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 12040046)

  • 21. Peroxynitrite- and nitrite-induced oxidation of dopamine: implications for nitric oxide in dopaminergic cell loss.
    LaVoie MJ; Hastings TG
    J Neurochem; 1999 Dec; 73(6):2546-54. PubMed ID: 10582617
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Akt is essential for insulin modulation of amphetamine-induced human dopamine transporter cell-surface redistribution.
    Garcia BG; Wei Y; Moron JA; Lin RZ; Javitch JA; Galli A
    Mol Pharmacol; 2005 Jul; 68(1):102-9. PubMed ID: 15795321
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An N-terminal threonine mutation produces an efflux-favorable, sodium-primed conformation of the human dopamine transporter.
    Fraser R; Chen Y; Guptaroy B; Luderman KD; Stokes SL; Beg A; DeFelice LJ; Gnegy ME
    Mol Pharmacol; 2014 Jul; 86(1):76-85. PubMed ID: 24753048
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Attenuation of dopamine transporter activity by alpha-synuclein.
    Wersinger C; Sidhu A
    Neurosci Lett; 2003 Apr; 340(3):189-92. PubMed ID: 12672538
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mazindol analogues as potential inhibitors of the cocaine binding site at the dopamine transporter.
    Houlihan WJ; Kelly L; Pankuch J; Koletar J; Brand L; Janowsky A; Kopajtic TA
    J Med Chem; 2002 Sep; 45(19):4097-109. PubMed ID: 12213053
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intracellular Ca2+ regulates amphetamine-induced dopamine efflux and currents mediated by the human dopamine transporter.
    Gnegy ME; Khoshbouei H; Berg KA; Javitch JA; Clarke WP; Zhang M; Galli A
    Mol Pharmacol; 2004 Jul; 66(1):137-43. PubMed ID: 15213305
    [TBL] [Abstract][Full Text] [Related]  

  • 27. N-terminal truncation of the dopamine transporter abolishes phorbol ester- and substance P receptor-stimulated phosphorylation without impairing transporter internalization.
    Granas C; Ferrer J; Loland CJ; Javitch JA; Gether U
    J Biol Chem; 2003 Feb; 278(7):4990-5000. PubMed ID: 12464618
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanisms of MPTP toxicity and their implications for therapy of Parkinson's disease.
    Watanabe Y; Himeda T; Araki T
    Med Sci Monit; 2005 Jan; 11(1):RA17-23. PubMed ID: 15614202
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dopamine transporter-dependent induction of C-Fos in HEK cells.
    Yatin SM; Miller GM; Norton C; Madras BK
    Synapse; 2002 Jul; 45(1):52-65. PubMed ID: 12112414
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Studies of the biogenic amine transporters. VIII: identification of a novel partial inhibitor of dopamine uptake and dopamine transporter binding.
    Rothman RB; Dersch CM; Carroll FI; Ananthan S
    Synapse; 2002 Mar; 43(4):268-74. PubMed ID: 11835522
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protein kinase C-mediated functional regulation of dopamine transporter is not achieved by direct phosphorylation of the dopamine transporter protein.
    Chang MY; Lee SH; Kim JH; Lee KH; Kim YS; Son H; Lee YS
    J Neurochem; 2001 May; 77(3):754-61. PubMed ID: 11331404
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dopamine transporter cysteine mutants: second extracellular loop cysteines are required for transporter expression.
    Wang JB; Moriwaki A; Uhl GR
    J Neurochem; 1995 Mar; 64(3):1416-9. PubMed ID: 7861176
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transporter-mediated actions of R-(-)-1-(benzofuran-2-yl)-2-propylaminopentane.
    Shimazu S; Tsunekawa H; Yoneda F; Katsuki H; Akaike A; Janowsky A
    Eur J Pharmacol; 2003 Dec; 482(1-3):9-16. PubMed ID: 14659999
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HEK-293 cells expressing the human dopamine transporter are susceptible to low concentrations of 1-methyl-4-phenylpyridine (MPP+) via impairment of energy metabolism.
    Storch A; Ludolph AC; Schwarz J
    Neurochem Int; 1999 Nov; 35(5):393-403. PubMed ID: 10517700
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Substrate transport and cocaine binding of human dopamine transporter is reduced by substitution of carboxyl tail with that of bovine dopamine transporter.
    Lee SH; Cho HK; Son H; Lee YS
    Neuroreport; 1997 Jul; 8(11):2591-4. PubMed ID: 9261833
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protein tyrosine kinase inhibitors alter human dopamine transporter activity in Xenopus oocytes.
    Doolen S; Zahniser NR
    J Pharmacol Exp Ther; 2001 Mar; 296(3):931-8. PubMed ID: 11181926
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Involvement of the NH2 terminal domain of catecholamine transporters in the Na(2+) and Cl(-)-dependence of a [3H]-dopamine uptake.
    Syringas M; Janin F; Giros B; Costentin J; Bonnet JJ
    Br J Pharmacol; 2001 Jun; 133(3):387-94. PubMed ID: 11375255
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dopamine efflux via wild-type and mutant dopamine transporters: alanine substitution for proline-572 enhances efflux and reduces dependence on extracellular dopamine, sodium and chloride concentrations.
    Itokawa M; Lin Z; Uhl GR
    Brain Res Mol Brain Res; 2002 Dec; 108(1-2):71-80. PubMed ID: 12480180
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Direct evidence that two cysteines in the dopamine transporter form a disulfide bond.
    Chen R; Wei H; Hill ER; Chen L; Jiang L; Han DD; Gu HH
    Mol Cell Biochem; 2007 Apr; 298(1-2):41-8. PubMed ID: 17131045
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Benzo- and cyclohexanomazindol analogues as potential inhibitors of the cocaine binding site at the dopamine transporter.
    Houlihan WJ; Ahmad UF; Koletar J; Kelly L; Brand L; Kopajtic TA
    J Med Chem; 2002 Sep; 45(19):4110-8. PubMed ID: 12213054
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.